NCT06956326RecruitingPhase 2
Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
Source: ClinicalTrials.gov · Last updated 4 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The overall purpose of this project is to develop and test an infrastructure that can ensure early and specialized rehabilitation for individuals with multiple sclerosis (MS) on their path to recovery from a relapse. If this project proves successful, it can therefore help optimize clinical practice and provide a significant contribution to the treatment of relapsing-remitting sclerosis.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- First submitted
- 1 May 2025
- Start date
- 1 May 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Lars Hvid
- Diseases
- Multiple sclerosis
- NCT number
- NCT06956326
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 64
- From 1 May 2025 to the primary completion date, 31 Dec 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- medical conditions or substantial cognitive impairments that hinder participation in the study (e.g. inability to perform or understand the intensive rehabilitation)
Other
- more than 6 months since onset of motor relapse
- pregnancy
Who the study is looking for
- admitted to the Danish MS Hospitals for an inpatient rehabilitation stay
- confirmed motor relapse (within the past 6 months) by a neurologist, with disability/ functional interference characterized by change in pyramidal, and/or cerebellar functional scores of 2 or higher
- completed steroid or other acute relapse treatment, if prescribed
- age over 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Danish MS Hospitals Coordinator of this site? Confirm its status | Haslev | Denmark | Recruiting |
| The Danish MS Hospitals Coordinator of this site? Confirm its status | Ry | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.